Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COMBINATION OF TOCILIZUMAB AND STEROIDS TO IMPROVE MORTALITY IN PATIENTS WITH SEVERE COVID-19 INFECTION: A SPANISH, MULTICENTER, COHORT STUDY

Belen Ruiz-Antoran, Aranzazu Sancho-Lopez, Ferran Torres, Victor Moreno-Torres, Itziar de Pablo Lopez de Abechuco, Paulina Garcia Lopez, Francisco Abad-Santos, Clara Maria Rosso Fernandez, Ana Aldea-Perona, Eva Montane, Ruth M Aparicio-Hernandez, Roser LLop Rius, Consuelo Pedros, Paloma Gijon, Carolina Hernandez Carballo, Maria Jose Pedrosa Martinez, Guillermo Prada-Ramallal, Lourdes Cabrera Garcia, Josefa Andrea Aguilar Garcia, Rocio Sanjuan-Jimenez, Evelyn Iveth Ortiz Barraza, Enrique Sanchez Chica, Ana Fernandez-Cruz, TOCICOV-study group.
doi: https://doi.org/10.1101/2020.09.07.20189357
Belen Ruiz-Antoran
1 Hospital Universitario Puerta de Hierro Majadahonda;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bruizantoran@gmail.com
Aranzazu Sancho-Lopez
1 Hospital Universitario Puerta de Hierro Majadahonda;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: asancho.hpth@gmail.com
Ferran Torres
2 Hospital Clinic, Barcelona;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ferran.torres@uab.cat
Victor Moreno-Torres
3 Hospital Universitario Puerta de Hierro-Majadahonda;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: victor.moreno.torres.1988@gmail.com
Itziar de Pablo Lopez de Abechuco
4 Hospital Universitario Ramon y Cajal;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: itziar.pablo@salud.madrid.org
Paulina Garcia Lopez
5 Hospital Universitario Torrecardenas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: paulina_glopez@hotmail.com
Francisco Abad-Santos
6 Hospital Universitario La Princesa;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: francisco.abad@salud.madrid.org
Clara Maria Rosso Fernandez
7 Hospital Universitario Virgen del Rocio;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: claram.rosso.sspa@juntadeandalucia.es
Ana Aldea-Perona
8 Consorcio Parc Salut Mar;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a.aldea@gmail.com
Eva Montane
9 Hospital Universitario Germans Trias i Pujol;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: emontane.germanstrias@gencat.cat
Ruth M Aparicio-Hernandez
10 Hospital Universitario Central de la Defensa Gomez Ulla;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rapaher@mde.es
Roser LLop Rius
11 Hospital Universitari de Bellvitge;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rllop@bellvitgehospital.cat
Consuelo Pedros
12 Hospital General Universitari de Valencia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pedros_cons@gva.es
Paloma Gijon
13 Hospital General Universitario Gregorio Maranon;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: palomigi@gmail.com
Carolina Hernandez Carballo
14 Hospital Universitario Nuestra Senora Candelaria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: carolinahdezcarballo@gmail.com
Maria Jose Pedrosa Martinez
15 Hospital Universitario Puerto Real;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mjose.pedrosa.sspa@juntadeandalucia.es
Guillermo Prada-Ramallal
16 Fundacion Instituto de Investigacion Sanitaria de Santiago de Compostela (FIDIS);
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: guillermo.jose.prada.ramallal@sergas.es
Lourdes Cabrera Garcia
17 Hospital Universitario Clinico San Carlos;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lcabreragarcia@gmail.com
Josefa Andrea Aguilar Garcia
18 Hospital Costa del Sol Marbella;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rocio Sanjuan-Jimenez
19 Hospital Universitario Virgen de la Victoria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evelyn Iveth Ortiz Barraza
4 Hospital Universitario Ramon y Cajal;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Enrique Sanchez Chica
1 Hospital Universitario Puerta de Hierro Majadahonda;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kyke1931@hotmail.com
Ana Fernandez-Cruz
1 Hospital Universitario Puerta de Hierro Majadahonda;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anafcruz999@gmail.com
  • Abstract
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background: We aimed to determine the impact of tocilizumab use in severe COVID-19 pneumonia mortality. Methods: We performed a multicentre retrospective cohort study in 18 tertiary hospitals in Spain, from March to April 2020. Consecutive patients admitted with severe COVID-19 treated with tocilizumab were compared to patients not treated with tocilizumab, adjusting by Inverse Probability of the Treatment Weights (IPTW). Tocilizumab effect in patients receiving steroids during the 48h following inclusion was analyzed. Results: During the study period, 506 patients with severe COVID-19 fulfilled inclusion criteria. Among them, 268 were treated with tocilizumab and 238 patients were not. Median time to tocilizumab treatment from onset of symptoms was 11 days (IQR 8-14). Global mortality was 23.7%. Mortality was lower in patients treated with tocilizumab than in controls (16.8% versus 31.5%, HR 0.514 [95CI 0.355-0.744], p<0.001; weighted HR 0.741 [95CI 0.619-0.887], p=0.001). Tocilizumab treatment reduced mortality by 14.7% relative to no tocilizumab treatment (RRR 46.7%). We calculated a number necessary to treat of 7. Among patients treated with steroids, mortality was lower in patients treated with tocilizumab than in those treated with steroids alone (10.9% versus 40.2%, HR 0.511 [95CI 0.352-0.741], p=0.036; weighted HR 0.6 [95CI 0.449-0.804], p<0.001) (Interaction p=0.094). Conclusions: These results show that survival of patients with severe COVID-19 is higher in patients treated with tocilizumab than in those not treated, and that tocilizumab effect adds to that of steroids administered to non-intubated cases with COVID-19 during the first 48 hours of presenting with respiratory failure despite of oxygen therapy. Randomised controlled studies are needed to confirm these results.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Registration: The protocol of the study was registered in EU PAS Register #EUPAS34415 on 31th March 2020 and publicly available at: http://www.encepp.eu/encepp/viewResource.htm?id=35237

Clinical Protocols

http://www.encepp.eu/encepp/viewResource.htm?id=35237

Funding Statement

No funding was received for this article.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by Spanish Agency for Medicine and Health Product and by the Institutional Review Board (CEIm) at Hospital Universitario Puerta de Hierro-Majadahonda (FIB-TOC-2020-01), and a waiver for the informed consent was granted. The study complied with the provisions in European Union (EU) and Spanish legislation on data protection and the Declaration of Helsinki 2013.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data sharing: After publication, the data will be made available to others on reasonable requests to the corresponding authors. A proposal with a detailed description of study objectives and statistical analysis plan will be needed for evaluation of the reasonability of requests. Additional materials might also be required during the process of evaluation. De-identified participant data will be provided after approval from the principal researchers of the Hospital Puerta de Hierro-Majadahonda.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted September 10, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COMBINATION OF TOCILIZUMAB AND STEROIDS TO IMPROVE MORTALITY IN PATIENTS WITH SEVERE COVID-19 INFECTION: A SPANISH, MULTICENTER, COHORT STUDY
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COMBINATION OF TOCILIZUMAB AND STEROIDS TO IMPROVE MORTALITY IN PATIENTS WITH SEVERE COVID-19 INFECTION: A SPANISH, MULTICENTER, COHORT STUDY
Belen Ruiz-Antoran, Aranzazu Sancho-Lopez, Ferran Torres, Victor Moreno-Torres, Itziar de Pablo Lopez de Abechuco, Paulina Garcia Lopez, Francisco Abad-Santos, Clara Maria Rosso Fernandez, Ana Aldea-Perona, Eva Montane, Ruth M Aparicio-Hernandez, Roser LLop Rius, Consuelo Pedros, Paloma Gijon, Carolina Hernandez Carballo, Maria Jose Pedrosa Martinez, Guillermo Prada-Ramallal, Lourdes Cabrera Garcia, Josefa Andrea Aguilar Garcia, Rocio Sanjuan-Jimenez, Evelyn Iveth Ortiz Barraza, Enrique Sanchez Chica, Ana Fernandez-Cruz, TOCICOV-study group.
medRxiv 2020.09.07.20189357; doi: https://doi.org/10.1101/2020.09.07.20189357
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
COMBINATION OF TOCILIZUMAB AND STEROIDS TO IMPROVE MORTALITY IN PATIENTS WITH SEVERE COVID-19 INFECTION: A SPANISH, MULTICENTER, COHORT STUDY
Belen Ruiz-Antoran, Aranzazu Sancho-Lopez, Ferran Torres, Victor Moreno-Torres, Itziar de Pablo Lopez de Abechuco, Paulina Garcia Lopez, Francisco Abad-Santos, Clara Maria Rosso Fernandez, Ana Aldea-Perona, Eva Montane, Ruth M Aparicio-Hernandez, Roser LLop Rius, Consuelo Pedros, Paloma Gijon, Carolina Hernandez Carballo, Maria Jose Pedrosa Martinez, Guillermo Prada-Ramallal, Lourdes Cabrera Garcia, Josefa Andrea Aguilar Garcia, Rocio Sanjuan-Jimenez, Evelyn Iveth Ortiz Barraza, Enrique Sanchez Chica, Ana Fernandez-Cruz, TOCICOV-study group.
medRxiv 2020.09.07.20189357; doi: https://doi.org/10.1101/2020.09.07.20189357

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (144)
  • Anesthesia (47)
  • Cardiovascular Medicine (419)
  • Dentistry and Oral Medicine (72)
  • Dermatology (49)
  • Emergency Medicine (147)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (174)
  • Epidemiology (4906)
  • Forensic Medicine (3)
  • Gastroenterology (185)
  • Genetic and Genomic Medicine (689)
  • Geriatric Medicine (72)
  • Health Economics (193)
  • Health Informatics (636)
  • Health Policy (322)
  • Health Systems and Quality Improvement (209)
  • Hematology (86)
  • HIV/AIDS (157)
  • Infectious Diseases (except HIV/AIDS) (5408)
  • Intensive Care and Critical Care Medicine (333)
  • Medical Education (96)
  • Medical Ethics (24)
  • Nephrology (77)
  • Neurology (692)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (128)
  • Occupational and Environmental Health (211)
  • Oncology (447)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (91)
  • Pain Medicine (37)
  • Palliative Medicine (18)
  • Pathology (131)
  • Pediatrics (201)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (88)
  • Psychiatry and Clinical Psychology (787)
  • Public and Global Health (1832)
  • Radiology and Imaging (328)
  • Rehabilitation Medicine and Physical Therapy (142)
  • Respiratory Medicine (257)
  • Rheumatology (87)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (63)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (38)